Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Journal of Clinical Investigation

• Publication date

  1984-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1172/JCI111429PMID 6746897PMCID PMC370484
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reaction of antithrombin III with thrombin bound to the vascular endothelium. Analysis in a recirculating perfused rabbit heart preparation.

  1984cited by this paper
• Anticoagulantly active heparin-like molecules from vascular tissue.

  1984cited by this paper
• Microvascular heparin-like species with anticoagulant activity.

  1983influential reference
• Evidence for serotonin binding in vitro by platelet factor 4 and beta-thromboglobulin.

  1983cited by this paper
• Antithrombin "Chicago": a functionally abnormal molecule with increased heparin affinity causing familial thrombophilia.

  1983cited by this paper
• INTERACTION OF THROMBIN WITH THE VASCULAR ENDOTHELIUM IN A RECIRCULATING LANGENDORFF RABBIT HEART PREPARATION *

  1982cited by this paper
• Identification in vitro of an endothelial cell surface cofactor for antithrombin III. Parallel studies with isolated perfused rat hearts and microcarrier cultures of bovine endothelium.

  1982cited by this paper
• Proteoglycan carrier of human platelet factor 4. Isolation and characterization.

  1982cited by this paper
• Heparin with two binding sites for antithrombin or platelet factor 4.

  1982cited by this paper
• Bystander suppression of tumor growth: evidence that specific targets and bystanders are damaged by injury to a common microvasculature.

  1982cited by this paper
• Differentiated microdomains on the luminal surface of the capillary endothelium. II. Partial characterization of their anionic sites

  1981cited by this paper
• Heparinase production by Flavobacterium heparinum

  1981cited by this paper
• Cultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growth

  1981cited by this paper
• Filling of microcirculation in skeletal muscles during timed India ink perfusion.

  1981cited by this paper
• The isolation and characterization of a specific antibody population directed against the thrombin antithrombin complex.

  1980cited by this paper
• The heparin binding site of antithrombin III. Evidence for a critical tryptophan residue.

  1980cited by this paper
• Clearance of thrombin from circulation in rabbits by high-affinity binding sites on endothelium. Possible role in the inactivation of thrombin by antithrombin III.

  1980cited by this paper
• The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.

  1980cited by this paper
• The binding of low molecular weight heparin to hemostatic enzymes.

  1980cited by this paper
• Platelet antiheparin proteins and antithrombin III interact with different binding sites on heparin molecule

  1979cited by this paper
• Binding of human thrombin to cultured human endothelial cells.

  1979cited by this paper
• Platelet factor 4: an inhibitor of collagenase.

  1978cited by this paper
• Inhibition of the binding of low-density lipoprotein to its cell surface receptor in human fibroblasts by positively charged proteins.

  1978cited by this paper
• High resolution two-dimensional electrophoresis of basic as well as acidic proteins.

  1977cited by this paper
• A rapid and sensitive proteolytic assay for human plasminogen and plasmin using radioiodinated alpha-casein.

  1977cited by this paper
• A rapid and sensitive proteolytic assay for human plasminogen and plasmin using radioiodinated α-casein

  1977cited by this paper
• Systemic expression of cutaneous basophil hypersensitivity.

  1977cited by this paper
• Statistical characterization of the random errors in the radioimmunoassay dose--response variable.

  1976cited by this paper
• Activation of human prothrombin by highly purified human factors V and X-a in presence of human antithrombin.

  1975cited by this paper
• Enzymatic degradation of heparin-related mucopolysaccharides from the surface of endothelial cell cultures.

  1975cited by this paper
• Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays.

  1974cited by this paper
• The purification and mechanism of action of human antithrombin-heparin cofactor.

  1973cited by this paper
• Anticoagulant Action of Heparin

  1973cited by this paper
• Characterization of a chondroitin 4 -sulfate proteoglycan carrier for heparin neutralizing activity (platelet factor 4 ) released from human blood platelets.

  1972cited by this paper
• [123] Heparinase and heparitinase from flavobacteria

  1972cited by this paper
• Evaluation of the isolated perfused rat hindquarter for the study of muscle metabolism.

  1971cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• The Heparin-binding Site of Antithrombin I 11

  year unknowncited by this paper

• Antibody-mediated multicellular pathophysiology of HIT and VITT: the dynamic roles of platelets, neutrophils, endothelial cells, and monocytes.

  2025cites this paper
• Blood Coagulation Factor IX: Structure, Function, and Regulation

  2025cites this paper
• Protein disulfide isomerase cleaves allosteric disulfides in histidine-rich glycoprotein to regulate thrombosis

  2024cites this paper
• Heparin treatment is associated with a delayed diagnosis of Alzheimer’s dementia in electronic health records from two large United States health systems

  2024cites this paper
• Platelet factor 4(PF4) and its multiple roles in diseases.

  2023cites this paper
• Hsa-miRNA-1278 is a Novel Predictor for the Hematoma Expansion of Intracerebral Hemorrhage

  2023cites this paper
• Platelets provide robustness of spatial blood coagulation to the variation of initial conditions.

  2023cites this paper
• Factor IXa variants resistant to plasma inhibitors enhance clot formation in vivo.

  2023cites this paper
• New perspectives on the induction and acceleration of immune-associated thrombosis by PF4 and VWF

  2023cites this paper
• Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder

  2022cites this paper
• Investigation of Cell Adhesion and Cell Viability of the Endothelial and Fibroblast Cells on Electrospun PCL, PLGA and Coaxial Scaffolds for Production of Tissue Engineered Blood Vessel

  2022cites this paper
• Functional non-glutaraldehyde treated porcine pericardium for anti-coagulation, anti-calcification, and endothelial proliferation bioprosthetic heart valves

  2022cites this paper
• Antithrombin and Its Role in Host Defense and Inflammation

  2021cites this paper
• Human endothelial cells and fibroblasts express and produce the coagulation proteins necessary for thrombin generation

  2021cites this paper
• Endotheliopathy in septic conditions: mechanistic insight into intravascular coagulation

  2021cites this paper
• Prothrombotic Phenotype in COVID-19: Focus on Platelets

  2021cites this paper
• Hemostatic Testing in Critically Ill Infants and Children

  2021cites this paper
• Hematologic Disorders

  2021cites this paper
• In Vitro Assessment of Cell and Tissue Compatibility

  2020cites this paper
• Drugs Used in Thromboembolic Disorders: An Insight into Their Mechanisms

  2019cites this paper
• Effects of nebulized antithrombin and heparin on inflammatory and coagulation alterations in an acute lung injury model in rats

  2019cites this paper
• Cardiac Tissue

  2019cites this paper
• 15 – Immobilization of peptides on cardiovascular stent

  2018cites this paper
• Haemostatic agent etamsylate in vitro and in vivo antagonizes anti‐coagulant activity of heparin

  2018cites this paper
• Homozygous Variant of Antithrombin lll : AT lll

  2018cites this paper
• Heparin-induced thrombocytopenia.

  2017cites this paper
• Placental Pharmacology---Implications for Therapy in Pregnancy

  2016cites this paper
• Coagulation and fibrinolysis

  2016cites this paper
• Regulation of Chemokine Activity – A Focus on the Role of Dipeptidyl Peptidase IV/CD26

  2016cites this paper
• Cardiovascular biomaterials: when the inflammatory response helps to efficiently restore tissue functionality?

  2014cites this paper
• In vitro assessment of blood compatibility: Residual and dynamic markers of cellular activation

  2013cites this paper
• Decreased thrombin activity by a Congolese herbal medicine used in sickle cell anemia.

  2013cites this paper
• Chapter II.3.3 – In Vitro Assessment of Cell and Tissue Compatibility

  2013cites this paper
• in vivo Platelet factor 4 enhances generation of activated protein C in vitro and

  2013cites this paper
• Recombinant Technology in Hemostasis and Thrombosis

  2012cites this paper
• Atherosclerosis and the pathogenesis of occlusive disease

  2012cites this paper
• The Management of Antithrombotic Medication in Skin Surgery

  2012cites this paper
• cells: localization, isolation, and characterization High-molecular weight kininogen is present in cultured human endothelial

  2011cites this paper
• Chapter 48 – Cardiac Tissue

  2011cites this paper
• megakaryocytes and platelets Characterization of vasoactive intestinal peptide receptors on human

  2011cites this paper
• Effects ofHypoxia on HeparanSulfate inBovine Aortic andPulmonary Artery Endothelial Cells

  2011cites this paper
• cells in response to bacterial endotoxin Hemoglobin enhances the production of tissue factor by endothelial

  2011cites this paper
• Effect of a prostaglandin I2 analog on the expression of thrombomodulin in liver and spleen endothelial cells after an extensive hepatectomy

  2011cites this paper
• Anticoagulant heparan sulfate to not clot--or not?

  2010cites this paper
• Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis.

  2010cites this paper
• human erythroleukemic cell line Cloning and characterization of platelet factor 4 cDNA derived from a

  2010cites this paper
• Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity

  2009cites this paper
• Avoiding intelligence failures in the cardiac catheterization laboratory: Strategies for the safe and rational use of dalteparin or enoxaparin during percutaneous coronary intervention.

  2009cites this paper
• The thrombogenicity of human umbilical vein endothelial cell seeded collagen modules.

  2008cites this paper
• Reprint of Crosstalk between inflammation and thrombosis

  2008cites this paper
• Role for heparan sulfate proteoglycan in thrombin-induced calcium transients and nitric oxide production in aortic endothelial cells

  2008cites this paper
• Association of albuminuria with impaired aortic elasticity and left ventricular diastolic dysfunction in type 2 diabetes.

  2008cites this paper
• Crosstalk between inflammation and thrombosis.

  2008cites this paper
• 60 – Cardiac Tissue

  2008cites this paper
• The development of hyaluronic acid biomaterials for vascular tissue engineering

  2008cites this paper
• Development of Methods for Measuring Protein C Inhibitor and Antithrombin: Use of Monoclonal Antibodies against the Reactive Center Loop-Inserted Forms of the Serpins Kjellberg, Margareta

  2007cites this paper
• Development of Methods for Measuring Protein C Inhibitor and Antithrombin: Use of Monoclonal Antibodies against the Reactive Center Loop-Inserted Forms of the Serpins

  2007cites this paper
• The influence of biomaterials on endothelial cell thrombogenicity.

  2007cites this paper
• Chemokines and thrombogenicity

  2007cites this paper
• An unexpected role for anticoagulant heparan sulfate proteoglycans in reproduction.

  2006cites this paper
• Anticoagulation and Antiplatelet Agents

  2006cites this paper
• Clinical and Research Applications of Markers of Thrombosis

  2006cites this paper
• U SE OF H EPARIN - COATED S TENTS IN N EUROVASCULAR I NTERVENTIONAL P ROCEDURES : P RELIMINARY E XPERIENCE WITH 10 P ATIENTS

  2006cites this paper
• The cleaved and latent forms of antithrombin are normal constituents of blood plasma: a quantitative method to measure cleaved antithrombin

  2006cites this paper
• Use of Heparin-coated Stents in Neurovascular Interventional Procedures: Preliminary Experience with 10 Patients

  2006cites this paper
• Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke

  2006cites this paper
• Intravascular Thrombosis in Discordant Xenotransplantation

  2006cites this paper
• Heparan Sulfate in Bovine Aortic and Pulmonary Artery Endothelial Cells

  2005cites this paper
• Role of Anticoagulant Heparan Sulfate in Mammalian Reproduction

  2005cites this paper
• DISORGANIZATION OF ENDOTHELIUM BY FIBRIN Weimar and Delvos 141 Loading of Fibrin Clots with Antibodies

  2005cites this paper
• Thromboepidemiology: identifying patients with heritable risk for thrombin-mediated thromboembolic events.

  2005cites this paper
• Modulation of blood coagulation and fibrinolysis by polyamines in the presence of glycosaminoglycans.

  2005cites this paper
• Effects of hemodilution, blood loss, and consumption on hemostatic factor levels during cardiopulmonary bypass.

  2005cites this paper
• Interaction of Factor XIa and Antithrombin in the Presence 1488 Blood

  2005cites this paper
• Antithrombin abnormalities and perinatal management.

  2005cites this paper
• Clinical Trials of Novel Anticoagulants for Severe Sepsis: A Tale of Three Molecules

  2004cites this paper
• Monocyte-derived neutrophil chemotactic factor (MDNCF/IL-8) resides in a gene cluster along with several other members of the platelet factor 4 gene superfamily

  2004cites this paper
• Role of glycosaminoglycans in cellular communication.

  2004cites this paper
• Tissue engineering in the vascular graft

  2004cites this paper
• Platelet factor 4 modulation of the thrombomodulin–protein C system

  2004cites this paper
• Crosstalk between inflammation and thrombosis.

  2004cites this paper
• COAGULATION, ANTICOAGULATION AND THROMBOSIS: MOLECULAR MECHANISMS

  2004cites this paper
• The role of endothelium in the pathogenesis of diabetic microangiopathy

  2004influential citation
• Arginine 25 and Arginine 28 of lactoferrin are critical for effective heparin neutralization in blood.

  2003cites this paper
• Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study.

  2003cites this paper
• Heparin derivatives as angiogenesis inhibitors.

  2003cites this paper
• Platelet factor 4 enhances generation of activated protein C in vitro and in vivo.

  2003cites this paper
• Effect of denuded endothelial cells on arginine amidase activity released from rabbit arteries

  2003cites this paper
• [Haemostaseological aspects of perioperative blood management].

  2003cites this paper
• Immune Vascular Injury in Heparin- Induced Thrombocytopenia

  2003cites this paper
• Inhibition of endothelial cell-mediated generation of activated protein C by direct and antithrombin-dependent thrombin inhibitors

  2003cites this paper
• How serpins change their fold for better and for worse.

  2003cites this paper
• Platelet factor 4 neutralizes heparan sulfate-enhanced antithrombin inactivation of factor Xa by preventing interaction(s) of enzyme with polysaccharide.

  2003cites this paper
• Hämostaseologische Aspekte des perioperativen Blutmanagements

  2003cites this paper
• Interaction of Angiogenic Growth Factors with Endothelial Cell Heparan Sulfate Proteoglycans

  2002cites this paper
• Antithrombin deficiency: issues in laboratory diagnosis.

  2002cites this paper
• Activated Platelets but Not Endothelial Cells Participate in the Initiation of the Consolidation Phase of Blood Coagulation*

  2002cites this paper
• Mice deficient in heparan sulfate 3-O-sulfotransferase-1: Normal hemostasis with unexpected perinatal phenotypes

  2002cites this paper
• Antithrombin Attenuates Microvascular Leakage and Leukocyte-Endothelial Interaction in Response to Endotoxin

  2002cites this paper
• Expression in Escherichia coli, purification and kinetic characterization of human heparan sulfate 3-O-sulfotransferase-1.

  2002cites this paper